Ascendis Pharma A/S

NASDAQ: ASND · Real-Time Price · USD
197.97
5.93 (3.09%)
At close: Aug 15, 2025, 3:59 PM
200.00
1.03%
After-hours: Aug 15, 2025, 06:18 PM EDT

Ascendis Pharma A/S Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
559.54M 392.16M 444.77M 446.27M
Short-Term Investments
n/a 7.28M 290.69M 235.8M
Long-Term Investments
13.57M 5.69M 30.42M 145.91M
Other Long-Term Assets
2.32M 2.13M 1.92M 1.81M
Receivables
177.44M 55.77M 11.91M 2.2M
Inventory
295.61M 208.93M 130.67M 75.41M
Other Current Assets
n/a n/a 13.72M 20.99M
Total Current Assets
1.06B 702.72M 923.47M 805.89M
Property-Plant & Equipment
98.71M 110.63M 129.09M 126.05M
Goodwill & Intangibles
4.03M 4.42M 4.83M 5.27M
Total Long-Term Assets
118.63M 122.87M 166.27M 279.04M
Total Assets
1.18B 825.59M 1.09B 1.08B
Account Payables
96.39M 94.57M 101.03M 59.42M
Deferred Revenue
936K 1.18M n/a 2.6M
Short-Term Debt
491.54M 11.23M 11.63M 7M
Other Current Liabilities
317.77M 32.72M 12.83M -3M
Total Current Liabilities
907.86M 197.34M 171.27M 100.36M
Long-Term Debt
365.08M 534.25M 387.56M n/a
Other Long-Term Liabilities
n/a 155.07M 172.16M 2.96M
Total Long-Term Liabilities
377.34M 773.94M 655.12M 100.93M
Total Liabilities
1.29B 971.28M 826.39M 201.29M
Total Debt
856.62M 644.26M 508.38M 104.96M
Common Stock
8.15M 7.75M 7.67M 7.65M
Retained Earnings
n/a -2.28B -1.86B -1.41B
Comprehensive Income
n/a -153.45M 255.67M 875.99M
Shareholders Equity
-105.71M -145.7M 263.35M 883.63M
Total Investments
13.57M 12.96M 321.11M 381.7M